Global Anti-Hypertensive Drugs Market Size, Status, Research and Forecast 2019

Published On: Sep 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 60448

In 2018, the global Anti-Hypertensive Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Anti-Hypertensive Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-Hypertensive Drugs development in United States, Europe and China.

The key players covered in this study
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
AstraZeneca
Daiichi Sankyo Company Limited
Takeda Pharmaceutical

Market segment by Type, the product can be split into
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators
Renin Inhibitors

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anti-Hypertensive Drugs status, future forecast, growth opportunity, key market and key players.
To present the Anti-Hypertensive Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anti-Hypertensive Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Diuretics
1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.4.4 Angiotensin Receptor Blockers (ARBs)
1.4.5 Calcium Channel Blockers
1.4.6 Beta Blockers
1.4.7 Alpha Blockers
1.4.8 Vasodilators
1.4.9 Renin Inhibitors
1.5 Market by Application
1.5.1 Global Anti-Hypertensive Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Anti-Hypertensive Drugs Market Size
2.2 Anti-Hypertensive Drugs Growth Trends by Regions
2.2.1 Anti-Hypertensive Drugs Market Size by Regions (2014-2025)
2.2.2 Anti-Hypertensive Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Anti-Hypertensive Drugs Market Size by Manufacturers
3.1.1 Global Anti-Hypertensive Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Anti-Hypertensive Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Anti-Hypertensive Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti-Hypertensive Drugs Key Players Head office and Area Served
3.3 Key Players Anti-Hypertensive Drugs Product/Solution/Service
3.4 Date of Enter into Anti-Hypertensive Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Anti-Hypertensive Drugs Market Size by Type (2014-2019)
4.2 Global Anti-Hypertensive Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Anti-Hypertensive Drugs Market Size (2014-2019)
5.2 Anti-Hypertensive Drugs Key Players in United States
5.3 United States Anti-Hypertensive Drugs Market Size by Type
5.4 United States Anti-Hypertensive Drugs Market Size by Application

6 Europe
6.1 Europe Anti-Hypertensive Drugs Market Size (2014-2019)
6.2 Anti-Hypertensive Drugs Key Players in Europe
6.3 Europe Anti-Hypertensive Drugs Market Size by Type
6.4 Europe Anti-Hypertensive Drugs Market Size by Application

7 China
7.1 China Anti-Hypertensive Drugs Market Size (2014-2019)
7.2 Anti-Hypertensive Drugs Key Players in China
7.3 China Anti-Hypertensive Drugs Market Size by Type
7.4 China Anti-Hypertensive Drugs Market Size by Application

8 Japan
8.1 Japan Anti-Hypertensive Drugs Market Size (2014-2019)
8.2 Anti-Hypertensive Drugs Key Players in Japan
8.3 Japan Anti-Hypertensive Drugs Market Size by Type
8.4 Japan Anti-Hypertensive Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Anti-Hypertensive Drugs Market Size (2014-2019)
9.2 Anti-Hypertensive Drugs Key Players in Southeast Asia
9.3 Southeast Asia Anti-Hypertensive Drugs Market Size by Type
9.4 Southeast Asia Anti-Hypertensive Drugs Market Size by Application

10 India
10.1 India Anti-Hypertensive Drugs Market Size (2014-2019)
10.2 Anti-Hypertensive Drugs Key Players in India
10.3 India Anti-Hypertensive Drugs Market Size by Type
10.4 India Anti-Hypertensive Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Anti-Hypertensive Drugs Market Size (2014-2019)
11.2 Anti-Hypertensive Drugs Key Players in Central & South America
11.3 Central & South America Anti-Hypertensive Drugs Market Size by Type
11.4 Central & South America Anti-Hypertensive Drugs Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anti-Hypertensive Drugs Introduction
12.1.4 Novartis Revenue in Anti-Hypertensive Drugs Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anti-Hypertensive Drugs Introduction
12.2.4 Pfizer Revenue in Anti-Hypertensive Drugs Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anti-Hypertensive Drugs Introduction
12.3.4 Johnson & Johnson Revenue in Anti-Hypertensive Drugs Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anti-Hypertensive Drugs Introduction
12.4.4 Sanofi Revenue in Anti-Hypertensive Drugs Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Lupin
12.5.1 Lupin Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anti-Hypertensive Drugs Introduction
12.5.4 Lupin Revenue in Anti-Hypertensive Drugs Business (2014-2019)
12.5.5 Lupin Recent Development
12.6 Ranbaxy Laboratories
12.6.1 Ranbaxy Laboratories Company Details
12.6.2 Company Description and Business Overview
12.6.3 Anti-Hypertensive Drugs Introduction
12.6.4 Ranbaxy Laboratories Revenue in Anti-Hypertensive Drugs Business (2014-2019)
12.6.5 Ranbaxy Laboratories Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Anti-Hypertensive Drugs Introduction
12.7.4 Merck Revenue in Anti-Hypertensive Drugs Business (2014-2019)
12.7.5 Merck Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Anti-Hypertensive Drugs Introduction
12.8.4 AstraZeneca Revenue in Anti-Hypertensive Drugs Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Daiichi Sankyo Company Limited
12.9.1 Daiichi Sankyo Company Limited Company Details
12.9.2 Company Description and Business Overview
12.9.3 Anti-Hypertensive Drugs Introduction
12.9.4 Daiichi Sankyo Company Limited Revenue in Anti-Hypertensive Drugs Business (2014-2019)
12.9.5 Daiichi Sankyo Company Limited Recent Development
12.10 Takeda Pharmaceutical
12.10.1 Takeda Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Anti-Hypertensive Drugs Introduction
12.10.4 Takeda Pharmaceutical Revenue in Anti-Hypertensive Drugs Business (2014-2019)
12.10.5 Takeda Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details